MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$14,100,000
Net loss
-$14,084,000
Series a preferred
stock dividend
$16,000
Benefit (provision) for
income taxes
-$45,000
Loss before income
taxes
-$14,129,000
Loss from operations
-$9,319,000
Total other expense,
net
-$4,810,000
Gains Losses On
Extinguishment Of Debt
$800,000
Other income, net
$215,000
Interest income
$83,000
Total operating
expenses
$9,319,000
Forward Sales Contract
Expense
-$5,847,000
Interest expense
-$27,000
General and
administrative
$5,163,000
Research and development
$4,156,000
Back
Back
Income Statement
source: myfinsight.com
Ernexa Therapeutics Inc. (ERNAW)
Ernexa Therapeutics Inc. (ERNAW)